Cryo-EM structure of y⁺LAT1/CD98hc with glutamine at 3.4 Å reveals sodium-binding site
Researchers from IRB Barcelona, CNIO and partner centres resolved the human amino acid transporter bound to L-glutamine and showed how sodium and arginine occupy the same site.

A team from IRB Barcelona, CNIO, the Barcelona Supercomputing Center, the University of Barcelona and other centres has published the cryo-EM structure of the human transporter y⁺LAT1/CD98hc (SLC7A7/SLC3A2) in Nature Communications on 14 November 2026 nature.com
Nature Communicationsnature.comOpen source ↗. The structure was resolved at 3.4 Å in an outward-open conformation with L-glutamine bound. The transporter mediates electroneutral exchange of cationic and neutral amino acids, and Na⁺ is required for efficient transport of neutral substrates.
Loss-of-function mutations in this transporter cause Lysinuric Protein Intolerance (LPI). According to the authors, emerging evidence also points to the physiological relevance of L-glutamine uptake in immune and bone cells. The cryo-EM data were collected at the Basque Resource for Electron Microscopy on a Titan Krios microscope with a K3 detector.
Glutamine pose and the sodium tetrad
The structure shows a non-canonical substrate-binding pose for glutamine, involving Cys320 in transmembrane helix 8. The authors combined docking, molecular dynamics simulations and functional assays to identify a Na⁺-binding tetrad made of Asn49, Ser131, Gly323 and Ser327. According to the study, this tetrad underlies the Na⁺-dependent transport of neutral amino acids.
Cationic substrates such as L-arginine occupy the same locus with their positively charged side chain nature.com
Nature Communicationsnature.comOpen source ↗. In this way they effectively replace the role of Na⁺ and enable Na⁺-independent exchange, the authors report.
Transport cycle
Mutagenesis and kinetic analyses support this mechanism. They also reveal a key role for Glu128 during transitions toward inward-facing conformations, which gives structural insight into the transport cycle.
The authors conclude that y⁺LAT1 integrates Na⁺ and substrate recognition to mediate selective exchange of neutral and cationic amino acids. The work describes the transport mechanism at the structural and biochemical level; it does not report clinical data. Correspondence is addressed to David Aparicio, Raúl Estévez and Manuel Palacín.



